article thumbnail

MyMD Pharmaceuticals Announces Fourth Quarter 2021 Initiation of Phase 2 Clinical Trial of MYMD-1 for Extending Healthy Lifespan

Cannabis Law Report

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. About MyMD Pharmaceuticals, Inc.

article thumbnail

Best strains and terpenes for pain management

The Cannigma

One of the most common uses of medical cannabis is to treat chronic pain. In fact, modern research on cannabis and pain dates back to before 1975. Over 10% of US adults have suffered from some degree of daily pain for at least three months, so the need for improved treatment is clear. How cannabis can help with pain.

Terpenes 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Gb Sciences Completes $8 Million Sale of Las Vegas Cannabis Facility

Cannabis Law Report

11, 2022 (GLOBE NEWSWIRE) — Gb Sciences, Inc. “We can now concentrate all our energies on advancing our plant-inspired, biopharmaceutical research and development programs into human clinical trials.” LAS VEGAS, Jan. “This is a landmark event for Gb Sciences,” said Chairman and CEO John Poss.

article thumbnail

North America Legal Cannabis Market Size, Share & Trends Analysis Report 2022 – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “North America Legal Cannabis Market Size, Share & Trends Analysis Report by Sources (Marijuana, Hemp), by Derivatives (CBD, THC), by End Use (Medical, Recreational), and Segment Forecasts, 2022-2028” report has been added to ResearchAndMarkets.com’s offering. from 2022 to 2028.

article thumbnail

Vice Article: Australians Can Get a Medicinal Cannabis Prescription for Pretty Much Anything

Cannabis Law Report

11 May 2022. This is despite a limited number of high-quality clinical trials investigating the drug’s efficacy for this condition. Pain, anxiety and sleep issues are often interconnected – chronic pain can also cause mental health and sleep issues.”. Here’s the Uni of Sydney press release.

article thumbnail

UK: David Hardstaff And John Binns Write For Open Access Government Exploring Shifting Sands In The UK CBD Industry

Cannabis Law Report

13 May 2022. By 2022, it is now difficult to find a high street or retail centre between John o’ Groats and Land’s End without CBD products for sale. However, observational studies have their limitations, which is why most have recently welcomed with open arms the UK Health Research Authority approved trial, Canpain.

Access 52
article thumbnail

Pioneering Medical Cannabis Down Under

SpeedWeed

After watching my brother self-medicate for his chronic pain for decades, I didn’t understand how cannabis was important to him as a medicine. I always thought he used his chronic pain as an “excuse” to self-administer what I thought was a toxic drug. . in 2014, I watched my brother walk into a cannabis clinic.